Logo image of LYB

LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LYB - NL0009434992 - Common Stock

52 USD
+3.33 (+6.84%)
Last: 1/14/2026, 7:35:21 PM
52 USD
0 (0%)
After Hours: 1/14/2026, 7:35:21 PM
Fundamental Rating

3

Taking everything into account, LYB scores 3 out of 10 in our fundamental rating. LYB was compared to 82 industry peers in the Chemicals industry. LYB has a bad profitability rating. Also its financial health evaluation is rather negative. LYB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year LYB was profitable.
  • In the past year LYB had a positive cash flow from operations.
  • In the past 5 years LYB has always been profitable.
  • In the past 5 years LYB always reported a positive cash flow from operatings.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • LYB has a Return On Assets of -3.59%. This is in the lower half of the industry: LYB underperforms 67.07% of its industry peers.
  • The Return On Equity of LYB (-11.44%) is worse than 67.07% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.64%, LYB is in line with its industry, outperforming 52.44% of the companies in the same industry.
  • LYB had an Average Return On Invested Capital over the past 3 years of 10.69%. This is above the industry average of 6.10%.
  • The 3 year average ROIC (10.69%) for LYB is well above the current ROIC(3.64%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROIC 3.64%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • LYB's Profit Margin has declined in the last couple of years.
  • LYB has a worse Operating Margin (3.65%) than 64.63% of its industry peers.
  • LYB's Operating Margin has declined in the last couple of years.
  • LYB has a Gross Margin of 9.19%. This is amonst the worse of the industry: LYB underperforms 84.15% of its industry peers.
  • LYB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.65%
PM (TTM) N/A
GM 9.19%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

  • LYB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, LYB has about the same amount of shares outstanding.
  • LYB has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LYB has a worse debt to assets ratio.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that LYB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • LYB has a Altman-Z score (1.93) which is comparable to the rest of the industry.
  • LYB has a debt to FCF ratio of 16.07. This is a negative value and a sign of low solvency as LYB would need 16.07 years to pay back of all of its debts.
  • LYB has a Debt to FCF ratio of 16.07. This is comparable to the rest of the industry: LYB outperforms 54.88% of its industry peers.
  • A Debt/Equity ratio of 1.02 is on the high side and indicates that LYB has dependencies on debt financing.
  • LYB's Debt to Equity ratio of 1.02 is on the low side compared to the rest of the industry. LYB is outperformed by 65.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Altman-Z 1.93
ROIC/WACC0.47
WACC7.76%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.57 indicates that LYB should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.57, LYB is not doing good in the industry: 67.07% of the companies in the same industry are doing better.
  • LYB has a Quick Ratio of 1.57. This is a bad value and indicates that LYB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.93, LYB is doing worse than 65.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.93
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

  • LYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.51%.
  • Measured over the past years, LYB shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.75% on average per year.
  • The Revenue for LYB has decreased by -20.07% in the past year. This is quite bad
  • Measured over the past years, LYB shows a small growth in Revenue. The Revenue has been growing by 3.02% on average per year.
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%

3.2 Future

  • Based on estimates for the next years, LYB will show a small growth in Earnings Per Share. The EPS will grow by 5.03% on average per year.
  • The Revenue is expected to decrease by -6.25% on average over the next years.
EPS Next Y-63.95%
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%
EPS Next 5Y5.03%
Revenue Next Year-25.57%
Revenue Next 2Y-14.05%
Revenue Next 3Y-9.63%
Revenue Next 5Y-6.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

  • LYB is valuated rather expensively with a Price/Earnings ratio of 19.19.
  • The rest of the industry has a similar Price/Earnings ratio as LYB.
  • The average S&P500 Price/Earnings ratio is at 27.33. LYB is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 15.63, which indicates a correct valuation of LYB.
  • 63.41% of the companies in the same industry are more expensive than LYB, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of LYB to the average of the S&P500 Index (24.12), we can say LYB is valued slightly cheaper.
Industry RankSector Rank
PE 19.19
Fwd PE 15.63
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • LYB's Enterprise Value to EBITDA is on the same level as the industry average.
  • 68.29% of the companies in the same industry are more expensive than LYB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.68
EV/EBITDA 9.92
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • A cheap valuation may be justified as LYB's earnings are expected to decrease with -10.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%

5

5. Dividend

5.1 Amount

  • LYB has a Yearly Dividend Yield of 11.50%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.34, LYB pays a better dividend. On top of this LYB pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, LYB pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.5%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.17%.
  • LYB has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of LYB decreased recently.
Dividend Growth(5Y)5.17%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

  • The earnings of LYB are negative and hence is the payout ratio. LYB will probably not be able to sustain this dividend level.
  • The dividend of LYB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-144.93%
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

LYONDELLBASELL INDU-CL A

NYSE:LYB (1/14/2026, 7:35:21 PM)

After market: 52 0 (0%)

52

+3.33 (+6.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-31
Earnings (Next)01-30
Inst Owners71.84%
Inst Owner Change0.17%
Ins Owners0.18%
Ins Owner Change-0.03%
Market Cap16.74B
Revenue(TTM)32.56B
Net Income(TTM)-1.21B
Analysts53.79
Price Target51.92 (-0.15%)
Short Float %8.06%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield 11.5%
Yearly Dividend5.31
Dividend Growth(5Y)5.17%
DP-144.93%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.36%
Min EPS beat(2)-23.45%
Max EPS beat(2)24.17%
EPS beat(4)2
Avg EPS beat(4)-4.8%
Min EPS beat(4)-23.45%
Max EPS beat(4)24.17%
EPS beat(8)4
Avg EPS beat(8)-1.26%
EPS beat(12)8
Avg EPS beat(12)5.26%
EPS beat(16)10
Avg EPS beat(16)2.78%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)0.76%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)-0.64%
Revenue beat(16)10
Avg Revenue beat(16)0.42%
PT rev (1m)-5.1%
PT rev (3m)-15.17%
EPS NQ rev (1m)-51.84%
EPS NQ rev (3m)-61.5%
EPS NY rev (1m)-12.99%
EPS NY rev (3m)-8.77%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-4.34%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE 19.19
Fwd PE 15.63
P/S 0.51
P/FCF 22.68
P/OCF 6.27
P/B 1.58
P/tB 1.77
EV/EBITDA 9.92
EPS(TTM)2.71
EY5.21%
EPS(NY)3.33
Fwd EY6.4%
FCF(TTM)2.29
FCFY4.41%
OCF(TTM)8.3
OCFY15.95%
SpS101.16
BVpS32.93
TBVpS29.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.81
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROCE 4.41%
ROIC 3.64%
ROICexc 3.89%
ROICexgc 4.08%
OM 3.65%
PM (TTM) N/A
GM 9.19%
FCFM 2.27%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
ROICexc(3y)11.83%
ROICexc(5y)12.68%
ROICexgc(3y)12.95%
ROICexgc(5y)13.92%
ROCE(3y)12.98%
ROCE(5y)14.24%
ROICexgc growth 3Y-25.81%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-25.6%
ROICexc growth 5Y-8.64%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Debt/EBITDA 4.18
Cap/Depr 138.59%
Cap/Sales 5.93%
Interest Coverage 250
Cash Conversion 103.45%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.93
Altman-Z 1.93
F-Score3
WACC7.76%
ROIC/WACC0.47
Cap/Depr(3y)123.27%
Cap/Depr(5y)130.2%
Cap/Sales(3y)4.01%
Cap/Sales(5y)4.66%
Profit Quality(3y)139.02%
Profit Quality(5y)124.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
EPS Next Y-63.95%
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%
EPS Next 5Y5.03%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%
Revenue Next Year-25.57%
Revenue Next 2Y-14.05%
Revenue Next 3Y-9.63%
Revenue Next 5Y-6.25%
EBIT growth 1Y-60.92%
EBIT growth 3Y-27.96%
EBIT growth 5Y-7.79%
EBIT Next Year-10.24%
EBIT Next 3Y6.13%
EBIT Next 5Y10.29%
FCF growth 1Y-79.05%
FCF growth 3Y-29.85%
FCF growth 5Y-2.67%
OCF growth 1Y-47.04%
OCF growth 3Y-20.83%
OCF growth 5Y-5.1%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 4 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 3 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to decline by -63.95% in the next year.